Based on the current U.S. prescribing information reviewed for 2026, neither semaglutide (Wegovy) nor tirzepatide (Zepbound) lists nail disorder as an adverse reaction. The labels therefore do not show that one medicine causes more nail problems than the other. They also do not prove that nail changes are impossible, because label silence cannot exclude rare, unrecognized, or separately reported events.
No head-to-head study or nail-specific comparative rate was identified in the reviewed sources. Both labels discuss hair loss associated with weight reduction, but hair loss is a different symptom and those figures cannot answer whether either medicine affects nails.
As an Amazon Associate I earn from qualifying purchases.
What the current labels say about nails
The narrow regulatory answer is the same for both medicines: nail disorder does not appear as a listed adverse reaction in the U.S. prescribing information reviewed for 2026. You can read the DailyMed prescribing information for WEGOVY (semaglutide) and the DailyMed prescribing information for ZEPBOUND (tirzepatide).
The Tool Desk
Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →Semaglutide (Wegovy)
The reviewed Wegovy label does not identify nail disorder as an adverse reaction in its clinical-trial safety information. It does identify hair loss in adults receiving the 2.4-mg dose in pooled weight-reduction studies, and the label associates those hair-loss events with weight reduction. That statement concerns hair, not nails.
#1 Best Overall
- [Ultra-Lightweight Ear Buds Designed for Small Ears] Each earbud weighs only 3.7g and features a compact, ergonomic in-ear design made especially for small ears. Secure, low-profile, and comfortable for workouts, all-day wear or overnight sleeping.The ultra-slim profile sits flush in your ear with no hard edges poking or rubbing, so you can even sleep on your side without discomfort.
- [Immersive Stereo Sound with TOZO OrigX Technology] TOZO OrigX tuning delivers clear vocals, balanced mids, and natural stereo sound for music, podcasts, and videos.
- [Long Battery Life for Daily Use] Get up to 7 hours of playtime on a single charge, with up to 32 hours total using the charging case—ideal for workdays, commuting, and extended listening sessions.
- [Bluetooth 5.3 & Stable Connection] Bluetooth 5.3 provides fast pairing, stable wireless performance, and reduced dropouts as you move around home or office.
- [Deep Bass with Clear Vocals] High-performance drivers produce punchy bass while keeping vocals clean and detailed for everyday listening.
Tirzepatide (Zepbound)
The reviewed Zepbound label likewise does not list nail disorder. It reports hair-loss events in pooled studies and states that “Hair loss adverse reactions in ZEPBOUND-treated patients were associated with weight reduction.” This is a labeled observation about hair and does not establish a nail effect or a nail-specific mechanism.
Side-by-side comparison
| Question | Semaglutide (Wegovy) | Tirzepatide (Zepbound) |
|---|---|---|
| Is nail disorder listed in the reviewed U.S. label? | No | No |
| Is there a nail-specific incidence rate? | Not stated in the reviewed label | Not stated in the reviewed label |
| Is there a direct head-to-head nail comparison? | No comparison was identified in the reviewed sources | |
| What related finding is labeled? | Hair loss associated with weight reduction | Hair loss associated with weight reduction |
This table supports a limited conclusion: the labels are silent on nail disorder for both drugs. It does not support ranking one drug as safer or riskier for nails.
Why the hair-loss percentages cannot answer a nail question
Hair and nails are different tissues and different clinical outcomes. A trial count for hair loss cannot be converted into a probability of brittle nails, ridges, discoloration, separation, or another nail change. Treating the hair figures as a proxy for nails would overstate what the labels show.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
Semaglutide hair-loss figure
In pooled adult weight-reduction studies, hair loss occurred in 3.3% of people receiving Wegovy 2.4 mg and 1.0% receiving placebo. The label describes these reactions as associated with weight reduction. These are hair-loss percentages, not nail-event percentages.
Rank #2
- 【IP68 Waterproof Multifunctinal Smart Watch】Torjalph fitness activity tracker smart watch is IP68 waterproof technology ,you can wear it when swimming,handwashing,it's rain-proof which means that you perform multiple exercise modes outside without worrying about sweat or rain corroding your fitness smart watch,and this watch equipped with a 230 mAh large capacity battery magnetic charging ,and this sports activity tracker watch can be used 5-7 days If fully charged.
- 【Larger 1.83'' Full Screen Watch & Multi-dial Selection】1.83 inch full HD color touch screen smart watch for men / women provides excellent 240*284 resolution image quality ,This Bluetooth smart watch offers a better touch experience and remarkable immersion and ,more than 200 watch faces for you to choose from App"Da Fit ", you can change the dial style according to your mood to wear keeping the world on your wrist
- 【Accurate Activity Tracker Smart Watch 】sports watch activity tracker uses sweat and dust resistant breathable silicone strap, our Fitness Tracker Smart Watch for Android iOS Phones supports 12 sports modes,walking,running,bicycle,swimming,badminton,basketball,football,rope skipping. This bluetooth calls smart watch for men women is lightweight and stylish, bringing more convenient and relaxing sports experience while also providing more protection.
- 【Your 24 Hour Personal Daily Health Monitor】Fitness watch for women men full touch screen IP67 waterproof bluetooth smartwatch for Android iOS Phones with heart rate blood pressure monitor multifunction Andriod smart watch with steps counter sleep monitor sports fitness watch, monitoring blood oxygen saturation allows you to understand your physical condition in real time to track fitness progress ,to know your health status in time.
- 【More Functions Bluetooth Call Smart Watch】This fitness activity smart watch full screen for iPhone and Android phones includes a bunch of new features including:The bluetooth smart watch can hang up the phone, receive and display WhatsAPP /Text /Facebook /Twitter /Messenger reminder.Support sedentary reminder, alarm clock, stopwatch, timer,weather information,music control, remote camera control compatible with Android 5.0 and above or iOS 9.0 and above smartphones.
Tirzepatide hair-loss figures
In pooled Zepbound Studies 1 and 2, hair loss was reported by 7.1% of treated women and 0.5% of treated men, compared with 1.3% of women and 0% of men receiving placebo. The label again associates the reactions with weight reduction. These sex-specific figures describe hair loss only; they do not estimate nail risk.
Why cross-trial arithmetic is misleading
The semaglutide and tirzepatide numbers come from different clinical-trial programs, with potentially different populations, follow-up periods, definitions, background treatments, and reporting practices. The Wegovy labeling cautions that adverse-reaction rates from separate trials should not be directly compared. Consequently, even the hair-loss percentages should not be used to claim that tirzepatide has more or less hair risk than semaglutide, much less to infer a nail difference.
What “not listed” means—and what it does not mean
Prescribing information summarizes adverse reactions detected and considered relevant in the studies and safety monitoring used for that product. When a nail disorder is not listed, the label has not established it as a recognized adverse reaction at a frequency or level that appears in that section. That is useful evidence, but it is not proof that no patient can ever experience a nail change while taking the medicine.
Label silence cannot rule out an uncommon event, an event that was not recognized in the available data, or a change caused by something other than the medicine. The reviewed sources do not establish a nail-specific causal pathway for either drug, do not provide an incidence estimate for nail changes, and do not determine whether a particular person’s nails changed because of treatment.
Rank #3
- [Low Noise High Fidelity] New bee guitar cord with 22AWG oxygen-free-copper center conductors provides enhanced signal transfer, the PVC insulation material and the high-density stranded copper double shield provide noise rejection for quiet operation
- [Ideal for Choice] New bee 1/4 straight and right angle metal connectors, ensures a secure connection in any instrument, pedal, or amp jack. L shape great fro on stage guitar stands
- [Wide Compatible] Suitable for mixer, power amplifier, microphone, effector, decoder, equalizer, electoronic organ, electric guitar, electric bass and other electronic equipments. Widely used in the installation of smart home, karaoke speaker, professional stage audio, etc
- [Easy Disassemble] Making incidental repairs quick and easy! Very nice, flexible cable
- [Dont Hesite to Order] 24 hours customer services and professional technology team are standing by
Timing alone cannot prove causation
If a nail change begins after starting or increasing a medicine, the timing is worth reporting but does not by itself demonstrate that the drug caused it. The same period may include rapid weight change, altered food intake, an underlying condition, another medicine, or an unrelated nail problem. The available evidence does not separate those possibilities for an individual patient.
Weight reduction is a separate clinical context
Both labels connect their hair-loss observations with weight reduction. That association should not be silently expanded to nails. A person losing weight may notice several changes at once, but the reviewed labeling does not show that either drug directly causes nail disorder or that one produces more nail changes than the other.
What to do if your nails change during treatment
A nail change deserves a clinical conversation even though neither label lists nail disorder. The American Academy of Dermatology advises people with GLP-1-related skin, hair, or nail concerns to communicate with their medical team and partner with a board-certified dermatologist. Its guidance is available in “How can GLP-1 drugs affect my skin, hair, and nails?”
Do these 3 things before closing this tab:
1Repair Windows errors before they cause bigger problems2Fix the driver behind crashes, sound loss and screen glitches3Clear out junk files and repair common Windows errors- Record what changed. Note which nails are involved, what you see (for example, a change in texture, color, shape, or attachment), when it started, and whether it is spreading or improving. Clear photographs taken under similar lighting can help a clinician compare changes over time.
- List treatment timing. Write down when you began semaglutide or tirzepatide, any dose changes, and when weight change or other symptoms occurred. Include prescription medicines, over-the-counter products, and supplements so the clinician can consider the full context.
- Contact the prescriber. Tell the clinician who manages the medicine rather than assuming the nail change is an expected side effect. Ask whether an examination, laboratory work, or review of other causes is appropriate for your situation.
- Consider dermatology evaluation. A board-certified dermatologist can examine the nails and look for causes that cannot be distinguished from a description alone. This is especially useful when changes persist, involve several nails, or are accompanied by other skin or hair concerns.
- Do not change the prescription on your own. Do not stop, reduce, or switch semaglutide or tirzepatide solely because a nail change appeared. Make medication decisions with the prescriber, who can weigh the nail concern against the reason the medicine was prescribed and your overall health.
Information to bring to the appointment
- A timeline of medication starts, dose changes, weight changes, and the first nail symptoms.
- Photographs showing the nails before and after the change, if available.
- A complete list of medicines, supplements, and relevant medical conditions.
- Details about pain, tenderness, swelling, drainage, injury, or changes in more than one nail.
- Any simultaneous hair or skin changes, while keeping those symptoms distinct from the nail complaint.
How clinicians can interpret the complaint
An evaluation is needed because “nail side effect” can describe many different observations. A clinician may first verify that the change is truly in the nail and then consider its distribution, timing, severity, and other exposures. The reviewed sources do not identify a single nail pattern that points specifically to semaglutide or tirzepatide.
Rank #4
- Digital Family Calendar: BSIMB digital calendar wall touch screen puts an end to your chaotic life. Designed for busy families, the digital calendar keeps you organised and in step with your family. Assign different colours and tasks to each family member to make family scheduling easier and more intuitive.
- Easy Setup and Auto-Sync: Plug in, connect to WLAN and auto-syn your electric calendar in minutes. Digital wall calendar compatible with Google calendar, iCloud calendar, Outlook calendar, Cozi calendar and Yahoo calendar. Add events directly on the device or through the ecalendar app. Electronic calendar stays current whether you're at work or traveling—no manual updates needed.
- All-In-One Home Assistant: Smart calendar builds habits and encourage independence with personalised chores. Display daily meal plan to reduce the daily ‘What's for dinner?’ stress. To-do lists keep track of everything you want. Turning chores into valuable achievements with stars and rewards, making life easier and more enjoyable.
- Manage Anytime Anywhere: BSIMB electronic calendar for family stay connected with the powerful ecalendar app. Access and manage your digital wall calendar anytime, anywhere with free features like stars & rewards, photo screensaver, chore charts, meals plans, to-do lists etc. Electronic planner paid features like Magic Import tailor advanced tools for users with special needs.
- Stay in Touch with Loved Ones: Share photos or videos from your phone to electronic wall calendar with app, instantly update your life moment, and keep in touch with your family, especially those who are far away; you can also surprise your smart calendar digital wall by sending him a wish card; it's also great for keeping tech-illiterate elders in touch with the youngsters.
Medication review
The prescriber can compare the timing of the nail change with treatment initiation and dose changes, review other medicines, and decide whether the benefit-risk balance requires any adjustment. A temporal association is a reason to investigate, not a diagnosis.
Broader health and nutrition context
The evidence limits identified for this question include rapid weight change, nutrition, an underlying condition, or another cause as possible explanations that have not been resolved by the labels. Discussing eating patterns, medical history, and concurrent symptoms helps the clinician avoid attributing every change to the injectable medicine.
Dermatologic examination
A dermatologist can inspect the nail plates and surrounding skin directly and determine whether testing or treatment is needed. The American Academy of Dermatology specifically recommends partnering with a board-certified dermatologist for GLP-1-related skin, hair, and nail concerns.
Recommended Free Tools
What evidence would be needed to show a difference
To establish that semaglutide and tirzepatide have different nail side-effect profiles, researchers would need a direct comparison using the same nail definitions, examination methods, follow-up period, and reporting rules. Ideally, participants would be assigned to the two treatments and nail outcomes would be collected systematically rather than inferred from spontaneous reports.
Useful evidence could also come from well-documented postmarketing reports that describe the nail finding, timing, competing causes, dose, outcome, and whether the change recurred after re-exposure. A revised prescribing label could add a nail reaction if accumulating evidence supports it. Neither a direct nail comparison nor a nail-specific regulatory statement was identified in the sources reviewed.
Answers to common questions
Can semaglutide or tirzepatide affect your nails?
The reviewed U.S. labels do not list nail disorder for either medicine, so they do not establish a known nail side effect. They also cannot exclude rare or unrecognized events. A new or worsening nail change should be discussed with the prescriber and, when appropriate, a board-certified dermatologist.
Are nail changes more likely with one drug?
There is no nail-specific comparative statistic in the reviewed sources, and no head-to-head nail-outcome study was identified. The available information does not support saying that semaglutide is safer or riskier than tirzepatide for nails.
Windows Errors? Fix Them Before They Spread
Repair common Windows errors and clear accumulated junk for a smoother, more stable PC - no reinstall needed.Free scan · no reinstallCrashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minuteCan the hair-loss percentages be used to estimate nail risk?
No. Hair loss and nail changes are separate outcomes. The reported percentages—3.3% with Wegovy 2.4 mg versus 1.0% with placebo, and sex-specific Zepbound figures from pooled Studies 1 and 2—describe hair loss associated with weight reduction, not nail events. Because the trial programs differ, their hair-loss rates should not be directly compared either.
Should you stop treatment if your nails change?
Do not stop, reduce, or switch a prescription medicine without speaking with the prescriber. Report the change, provide its timeline, and ask whether a dermatology assessment or evaluation for other causes is needed.
Bottom line for the nail comparison
As of the 2026 U.S. labeling reviewed here, semaglutide and tirzepatide look the same on the narrow nail question: neither label lists nail disorder, and no direct comparison shows a difference. Both labels contain hair-loss information associated with weight reduction, but that evidence cannot be used to infer nail effects. If your nails change during treatment, document the pattern, contact your medical team, and consider a board-certified dermatologist rather than assuming the medicine is—or is not—the cause.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
